Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $1.3 million.

  • Artiva Biotherapeutics' Treasury Shares changed N/A to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $506845.0 for FY2024, which is 215124.37% up from last year.
  • Per Artiva Biotherapeutics' latest filing, its Treasury Shares stood at $1.3 million for Q3 2025.
  • Over the past 5 years, Artiva Biotherapeutics' Treasury Shares peaked at $1.5 million during Q1 2025, and registered a low of $22514.0 during Q4 2023.
  • In the last 3 years, Artiva Biotherapeutics' Treasury Shares had a median value of $1.3 million in 2025 and averaged $957810.2.
  • The largest annual percentage gain for Artiva Biotherapeutics' Treasury Shares in the last 5 years was 215124.37% (2024), contrasted with its biggest fall of 215124.37% (2024).
  • Quarter analysis of 3 years shows Artiva Biotherapeutics' Treasury Shares stood at $22514.0 in 2023, then skyrocketed by 2151.24% to $506845.0 in 2024, then skyrocketed by 165.07% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.4 million for Q2 2025, and $1.5 million during Q1 2025.